Labeler
Zydus Lifesciences Limited NDC Codes
Zydus Lifesciences Limited lists 657 finished drug products in the FDA NDC Directory under NDC labeler codes 65841, 70771.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Selexipag, Isotretinoin, dasatinib, brivaracetam, tofacitinib, Diltiazem hydrochloride, Eltrombopag, Valsartan, Verapamil hydrochloride, gabapentin, oxcarbazepine, sacubitril and valsartan, minocycline hydrochloride, Zituvimet XR, Sitagliptin and Metformin Hydrochloride
- Active ingredients
- Selexipag, Valsartan, Isotretinoin, Dasatinib, Sitagliptin, Metformin hydrochloride, Brivaracetam, Tofacitinib citrate, Diltiazem hydrochloride, Eltrombopag olamine, Verapamil hydrochloride, Gabapentin
- NDC labeler codes
- 65841, 70771
- Strengths (from the 100 most recently listed products)
- Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1; Metformin hydrochloride 500 mg/1; Sitagliptin 100 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Tofacitinib citrate 10 mg/1; Fluorescein sodium 100 mg/mL; Fluorescein sodium 250 mg/mL; Diltiazem hydrochloride 30 mg/1; Diltiazem hydrochloride 60 mg/1; Diltiazem hydrochloride 90 mg/1; Diltiazem hydrochloride 120 mg/1; Verapamil hydrochloride 120 mg/1; Verapamil hydrochloride 180 mg/1; Verapamil hydrochloride 240 mg/1; Tofacitinib citrate 11 mg/1; Tofacitinib citrate 22 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Tablet, Film coated, Extended release, Injection, Kit, Injection, Solution, Tablet, Extended release, Capsule, Extended release, Tablet, For suspension, Gel, Powder, For solution, Shampoo, Cream, Injection, Powder, Lyophilized, For solution, Capsule, Coated pellets, Patch, Extended release
- Routes
- Oral, Intravenous, Topical, Intramuscular, Subcutaneous, Transdermal
- Drug classes (FDA established)
- Prostacyclin Receptor Agonist, Calcium Channel Blocker, Angiotensin 2 Receptor Blocker, Serotonin Reuptake Inhibitor, Retinoid, Kinase Inhibitor, Biguanide, Dipeptidyl Peptidase 4 Inhibitor, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Anti-epileptic Agent, Neprilysin Inhibitor, Tetracycline-class Drug, Diagnostic Dye, Sodium-Glucose Cotransporter 2 Inhibitor, Sulfone, Serotonin-4 Receptor Agonist, Amide Local Anesthetic, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Corticosteroid, Cholinergic Receptor Agonist, Calcitonin, Oxidation-Reduction Agent, Antiparasitic, Pediculicide, Endothelin Receptor Antagonist, Nitroimidazole Antimicrobial, Xanthine Oxidase Inhibitor, Histamine-2 Receptor Antagonist, Nonsteroidal Anti-inflammatory Drug, Azole Antifungal, Antiarrhythmic, l-Thyroxine, Anticholinergic
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 171 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| doxepin | Doxepin hydrochloride 3 mg/1 | TabletOral | 70771-1528 | 70771-1528-0070771-1528-0170771-1528-03+3 more | — |
| doxepin | Doxepin hydrochloride 6 mg/1 | TabletOral | 70771-1529 | 70771-1529-0070771-1529-0170771-1529-03+3 more | — |
| Baclofen | Baclofen 15 mg/1 | TabletOral | 70771-1868 | 70771-1868-01 | — |
| atorvastatin calcium | Atorvastatin calcium trihydrate 10 mg/1 | TabletOral | 70771-1875 | 70771-1875-0070771-1875-0570771-1875-09 | — |
| atorvastatin calcium | Atorvastatin calcium trihydrate 20 mg/1 | TabletOral | 70771-1876 | 70771-1876-0070771-1876-0570771-1876-09 | — |
| atorvastatin calcium | Atorvastatin calcium trihydrate 40 mg/1 | TabletOral | 70771-1877 | 70771-1877-0070771-1877-0570771-1877-09 | — |
| atorvastatin calcium | Atorvastatin calcium trihydrate 80 mg/1 | TabletOral | 70771-1878 | 70771-1878-0070771-1878-0570771-1878-09 | — |
| Theophylline | Theophylline anhydrous 300 mg/1 | Tablet, Extended releaseOral | 70771-1782 | 70771-1782-01 | — |
| Theophylline | Theophylline anhydrous 450 mg/1 | Tablet, Extended releaseOral | 70771-1783 | 70771-1783-01 | — |
| Dexamethasone | Dexamethasone 1 mg/1 | TabletOral | 70771-1706 | 70771-1706-01 | — |
| Dapsone | Dapsone 75 mg/g | GelTopical | 70771-1538 | 70771-1538-0270771-1538-0370771-1538-08 | — |
| Darunavir | Darunavir 600 mg/1 | Tablet, Film coatedOral | 70771-1745 | 70771-1745-0570771-1745-0670771-1745-08 | — |
| Darunavir | Darunavir 800 mg/1 | Tablet, Film coatedOral | 70771-1746 | 70771-1746-0370771-1746-0570771-1746-09 | — |
| Tretinoin | Tretinoin 1 mg/g | CreamTopical | 70771-1873 | 70771-1873-0270771-1873-04 | — |
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | 70771-1699 | 70771-1699-01 | — |
| Dexamethasone | Dexamethasone 6 mg/1 | TabletOral | 70771-1700 | 70771-1700-01 | — |
| Dexamethasone | Dexamethasone 2 mg/1 | TabletOral | 70771-1701 | 70771-1701-01 | — |
| Dexamethasone | Dexamethasone .5 mg/1 | TabletOral | 70771-1704 | 70771-1704-01 | — |
| Dexamethasone | Dexamethasone .75 mg/1 | TabletOral | 70771-1705 | 70771-1705-01 | — |
| Dexamethasone | Dexamethasone 1.5 mg/1 | TabletOral | 70771-1707 | 70771-1707-01 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | 70771-1778 | 70771-1778-07 | — |
| Chlorpromazine Hydrochloride | Chlorpromazine hydrochloride 25 mg/mL | InjectionIntramuscular | 70771-1779 | 70771-1779-07 | — |
| Sitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 70771-1869 | 70771-1869-0670771-1869-08 | — |
| Sitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | 70771-1870 | 70771-1870-0670771-1870-08 | — |
| Zituvimetsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 70771-1859 | 70771-1859-0670771-1859-08 | — |
| Zituvimetsitagliptin and metformin hydrochloride | Sitagliptin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | 70771-1860 | 70771-1860-0670771-1860-08 | — |
| gabapentin | Gabapentin 600 mg/1 | TabletOral | 70771-1862 | 70771-1862-0470771-1862-0570771-1862-09 | — |
| gabapentin | Gabapentin 300 mg/1 | TabletOral | 70771-1861 | 70771-1861-0270771-1861-0570771-1861-09 | — |
| Mirabegron | Mirabegron 25 mg/1 | Tablet, Extended releaseOral | 70771-1752 | 70771-1752-0170771-1752-0370771-1752-09 | — |
| Mirabegron | Mirabegron 50 mg/1 | Tablet, Extended releaseOral | 70771-1753 | 70771-1753-0170771-1753-0370771-1753-09 | — |
| zinc sulfate | Zinc sulfate 1 mg/mL | Injection, SolutionIntravenous | 70771-1848 | 70771-1848-07 | — |
| zinc sulfate | Zinc sulfate 3 mg/mL | Injection, SolutionIntravenous | 70771-1849 | 70771-1849-07 | — |
| zinc sulfate | Zinc sulfate 5 mg/mL | Injection, SolutionIntravenous | 70771-1850 | 70771-1850-07 | — |
| Methylene blue | Methylene blue 5 mg/mL | InjectionIntravenous | 70771-1767 | 70771-1767-05 | — |
| Methylene blue | Methylene blue 5 mg/mL | InjectionIntravenous | 70771-1768 | 70771-1768-05 | — |
| Zituviositagliptin | Sitagliptin 25 mg/1 | TabletOral | 70771-1770 | 70771-1770-0370771-1770-09 | — |
| Zituviositagliptin | Sitagliptin 50 mg/1 | TabletOral | 70771-1771 | 70771-1771-0370771-1771-09 | — |
| Zituviositagliptin | Sitagliptin 100 mg/1 | TabletOral | 70771-1772 | 70771-1772-0370771-1772-09 | — |
| Sitagliptin | Sitagliptin 25 mg/1 | TabletOral | 70771-1790 | 70771-1790-0370771-1790-09 | — |
| Sitagliptin | Sitagliptin 50 mg/1 | TabletOral | 70771-1791 | 70771-1791-0370771-1791-09 | — |
| Sitagliptin | Sitagliptin 100 mg/1 | TabletOral | 70771-1792 | 70771-1792-0370771-1792-09 | — |
| norelgestromin and ethinyl estradiol | Norelgestromin 150 ug/mg; Ethinyl estradiol 35 ug/mg | PatchTransdermal | 70771-1777 | 70771-1777-03 | — |
| Topiramate | Topiramate 200 mg/1 | Capsule, Extended releaseOral | 70771-1858 | 70771-1858-0170771-1858-0370771-1858-05+1 more | — |
| pitavastatin calcium | Pitavastatin calcium 1 mg/1 | TabletOral | 70771-1784 | 70771-1784-09 | — |
| pitavastatin calcium | Pitavastatin calcium 2 mg/1 | TabletOral | 70771-1785 | 70771-1785-09 | — |
| pitavastatin calcium | Pitavastatin calcium 4 mg/1 | TabletOral | 70771-1786 | 70771-1786-09 | — |
| estradiol | Estradiol .014 mg/d | PatchTransdermal | 70771-1400 | 70771-1400-04 | — |
| estradiol | Estradiol .025 mg/d | PatchTransdermal | 70771-1401 | 70771-1401-04 | — |
| estradiol | Estradiol .0375 mg/d | PatchTransdermal | 70771-1402 | 70771-1402-04 | — |
| estradiol | Estradiol .05 mg/d | PatchTransdermal | 70771-1403 | 70771-1403-04 | — |
Zydus Lifesciences Limited: common questions
- What is Zydus Lifesciences Limited's NDC labeler code?
- 65841, 70771. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Lifesciences Limited?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.